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Abstract
Backgrounds: Down syndrome (DS), caused by triplication of human chromosome 21, is the most common
aneuploidies. The main characteristic of DS patients is intellectual disability. MicroRNAs (miRNAs) play important
regulatory roles in various biological processes, such as embryonic development, cell differentiation, proliferation
and apoptosis. Several miRNAs have shown association with DS. However, the role of miRNAs in DS patients has
not been well elaborated.
Methods: In this research, total RNA extracted from fetal hippocampal tissues was used to analyze miRNA and
mRNA expression via Affymetrix miRNA 4.0 and PrimeView Human Gene Expression Array, respectively. Then miRNA
and gene expression profiles were integrated by correlation analysis to identify dysregulated miRNAs with their
predicted target mRNAs. Microarray data were further validated by real-time PCR. Regulation of zeste homolog 2
(EZH2) expression by hsa-miR-138 was determined by luciferase reporter assay.
Results: We analyzed microRNA expression profile in hippocampal tissues from DS fetal using miRNA microarray.
Further with the use of mRNA microarray data, we integrate miRNA expression and mRNA expression
in hippocampus of trisomy 21 fetus to elucidate the mechanism that underlying DS abnormalities. We
characterized the repertoire of specific miRNAs involved in hippocampus in trisomy 21 patients, highlighting
hsa-miR-138 and hsa-miR-409, in particular the importance of hsa-miR-138, especially the -5p strand.
Furthermore, the expression level of predicted target genes of hsa-miR-138-5p in trisomy 21 fetus, including
zeste homolog 2 (EZH2) were further confirmed. In addition, luciferase assay indicated that EZH2 was a
direct target of hsa-miR-138 in HEK293T cells.
Conclusion: The function of hsa-miR-138-5p and its target EZH2 was involved in hippocampus in DS
patients. Our findings provide a clue to study the underlying molecular mechanisms in DS patients, and its
potential contribution in improving understanding of intellectual disability development in DS patients.
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Background
Down syndrome (DS), or trisomy 21 [MIM: 190685],
is a common chromosomal abnormality. This disease
is caused by an extra copy of chromosomal 21 and
therefore called trisomy. The incidence of DS is about
1:700 births and the incidence increases with high
maternal age [1]. There are various phenotypes in DS
population, including craniofacial abnormality, learn-
ing disabilities, congenital heart disease, leukemia’s,
Alzheimer’s disease and a variety of physical features
such as slanted eye, abnormal pattern of fingerprint,
large tongue [2, 3]. The main neurological deficiency
in DS patients is intellectual disability and early onset
of Alzheimer’s disease [4]. So far, several genes have
been associated with Alzheimer’s disease in DS pa-
tients, such as APP [5], BACE2 [6] and PICALM [7].
However, the role of miRNA in intellectual disability
of DS patients is largely unknown. Elucidation of
neurological deficiency in DS patients will contribute
to better understand of this disease.
MicroRNAs (miRNAs) are small single stranded non-
coding RNAs. MiRNAs regulate gene expression post-
transcriptionally via binding with complementary targets
resulting in inhibition of target mRNA translation [8–10].
Increasing evidence indicates that miRNAs play important
roles in a large variety of biological processes such as de-
velopment, differentiation, proliferation and apoptosis [11].
So far, several miRNAs have been implicated in Down syn-
drome. For example, hsa-miR-155 contributes to reduce
the incidence of hypertension in DS patients [12].
Fetal hippocampus consists of Ammon’s horn, dentate
gyrus, entorhinal cortex, parasubiculum, presubiculum,
and subicular complex. Hippocampus is involved in
spatial learning, short-term memory and long-term
memory [13]. Opperman et al. have showed the differ-
ence protein expression in fetal human brain between
DS and control subjects [14]. However, the function of
miRNAs in DS is still largely undefined. The study of
miRNA on hippocampus of DS patients will shed light
on the mechanism that underlying neurological defi-
ciency in DS patients.
In this study, we tried to establish a comprehensive
correlation between the miRNA expression and target
gene regulation in hippocampus in Down syndrome by
integration of miRNA and mRNA expression data. The
results implicated that hsa-miR-138 and its targets
enhancer of zeste homolog 2 (EZH2) were involved in
DS patients and potentially contributed in neurological
deficiency in DS patients.
Methods
Sample preparation
Four fetal brains that were diagnosed as trisomy 21 by
amniocentesis analysis were obtained at abortions in the
Table 1 Primer pairs used for quantitative real-time PCR
Name Sequence (5′- 3′)















































RT Reverse transcript primer, AS anti-sense primer, Fw forward primer, Re
reverse primer
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pregnancy of 16–20 weeks. The other three were
obtained at spontaneous abortions in the pregnancy
of 16–20 weeks and were diagnosed as diploid con-
trols. The hippocampus in fetal were quickly dissected
out from the surrounding tissues, and then were fro-
zen in liquid nitrogen.
RNA isolation
Total RNA of fetal hippocampal tissues of DS (n = 4)
and diploid controls (n = 3) was extracted respectively
using the Trizol reagent (Invitrogen) according to manu-
facture’s protocol as we published previously [15].
MiRNA microarray analysis
Total RNA of DS (n = 3) and diploid controls (n = 3)
was purified by mirVana miRNA Isolation Kit
(Ambion). The miRNA expression profiles were gen-
erated by using the Affymetrix GeneChip miRNA
Array v. 4.0 (Affymetrix). Briefly, the flashTag Biotin
RNA Labeling Kit (Affymetrix) was used to label of
1 μg of total RNA, followed by the hybridization
overnight according to the manufacturer’s instruc-
tions. After washed and stained using the Affymetrix
GeneChip Hybridization Wash and Stain Kit, the
miRNA chips were then scanned with the Affymetrix
GeneChip Scanner 3000 (Affymetrix).
Fig. 1 Hierarchical clustering of DS fetal samples and control samples. Hierarchical clustering of all covered human mature miRNAs. Samples
are shown in the columns and miRNAs in the rows. The boxes in color indicate the log2 intensities of the miRNAs, with blue indicating low
expression and yellow indicating high expression
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mRNA microarray analysis
Total RNA (0.1 μg) of DS (n = 3) and diploid controls
(n = 3) was employed for the expression analysis with
PrimeView Human Gene Expression Array (Affyme-
trix). RNA was labeled by biotin using the GeneChip
3′ IVT labeling kit (Affymetrix). After hybridization
overnight, the chips were washed and stained by Gen-
eChip Hybridization, wash, and stain Kit (Affymetrix)
according to the manufacturer’s protocols. The hybridized
chips were scanned by GeneChip Scanner 3000.
Microarray expression data Analysis
The CEL-files of the raw data were obtained by Affyme-
trix GeneChip Command Console Software (Affymetrix).
SAM (significance analysis of microarray) with the R
package was used to identify differentially expressed
miRNA and gene probe sets between DS fetal hippo-
campus and controls. Probe sets were considered as bio-
logically significant if the fold changes (FC) are over 2 or
less than 0.05 and a false discovery rate (FDR) < 0.05.
Prediction of target mRNAs of miRNAs
We predicted the target mRNAs of the miRNA using
the bioinformatics prediction tool including miR-
Walk, miRanda, miRDB, RNA, DIANAmT, RNAhy-
brid, PICTAR4, PICTAR5, PITA, RNA22 and
TargetScan. The selection criteria is correlation > 0.99
or correlation < −0.99, and p value < 0.05.
Detection of miRNA expression with real-time PCR
Total RNA of DS (n = 4) and diploid controls (n = 3) was
extracted respectively by Trizol reagent, followed by
purification by mirVana miRNA Isolation Kit, and then
was reversely transcribed into cDNA by M-MLV Reverse
Transcriptase (Invitrogen). Real-time PCR was carried
out using SYBR Green master mix (Applied Biosystems)
according to the manufacturer’s instructions on a 7500
Fast Real-Time PCR system (Applied Biosystems) and
analyzed with the SDS analysis software package (version
2.0.1, Applied Biosystems). Samples were analyzed in
triplicate and all the PCR primers were purchased from
Invitrogen (Table 1). The U6 snRNA was used as the in-
ternal standard control.
Detection of mRNA expression with real-time PCR
The real-time PCR to detect mRNA expression was car-
ried out as we published previously [15]. Briefly, the total
RNA of DS (n = 4) and diploid controls (n = 3) was re-
spectively transcribed by M-MLV Reverse Transcriptase
(Invitrogen), real-time PCR was run in a final reaction
volume of 20 μl by SYBR Green master mix (Applied
Biosystems) on the Applied Biosystems 7500 Fast
Real-Time PCR System. All samples were analyzed in
triplicate and all the PCR primers were ordered from
Invitrogen (Table 1). GAPDH served as the reference.
Real-time PCR results analysis
Real-time PCR results were calculated using the 2-ΔΔCt
method. The ratio of expression in DS hippocampal tis-
sues relative to the control tissues more than 1.0 was
considered as obvious increased and less than 1.0 was
considered as decreased.
Plasmid construction and Luciferase reporter assay
The 3′UTR of EZH2 was amplified by PCR from gen-
omic DNA of HEK293T cells with the following primers:
Forward: 5′ AGGTCTAGACCTCTGAAACAGCTGCC
TTA 3′ and Reverse: 5′ CCTGAGCTCGCATTATTGC
AAAAATTCAC 3′. The 3′UTR was cloned downstream
Table 2 The increased mRNA located on chromosome 21
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of the luciferase coding sequence in the pMIR-REPORT
Luciferase vector (Promega). The construct was con-
firmed by sequencing. Hsa-miR-138 mimics and none-
target control were purchased from GenePharma. And
the sequence are as follows: hsa-miR-138 mimics,
Forward: 5′AGCUGGUGUUGUGAAUCAGGCCG 3′
and Reverse: 5′GCCUGAUUCACAACACCAGCUUU
3′; none-target control, Forward: 5′ UUCUCCGAAC
GUGUCACGUTT 3′and Reverse: 5′ ACGUGACACGU
UCGGAGAATT 3′.
HEK293T cells were plated in 24-well dishes over-
night before transfection. Hsa-miR-138 mimics or
none-target control was transfected into HEK293T
cells as well as 200 ng of pMIR-REPORT-EZH2 and
20 ng of pRL-renilla by lipofectmine 2000 (Invitro-
gen). Medium was changed 6 h later. After 48 h,
luciferase assay was performed with dual-luciferase
reporter assay systems (Promega) according to the
manufacturer’s instructions. Measurements were car-
ried out in triplicates and expressed as mean ± SD.
Three independent transfection experiments were
performed.
Statistics analysis
Statistical analysis was performed using SPSS 13.0 soft-
ware. The values are presented as mean ± SD. The differ-
ences between two groups were calculated by Student’s
t-test. P < 0.05 was considered as statistically significant
difference.
Results
Differentially expressed miRNAs in DS group versus
control group
MiRNA expression profiles were compared between DS
group and control group. Of all the miRNAs measured,
seventy-two mature miRNAs that were significantly up-
Fig. 2 Heatmap of mRNA expression in fetal hippocampus of DS fetal cohorts and control cohorts. Hierarchical clustering of all samples based
on the log2 expression values of the top 40 most variable mRNAs. Samples are shown in the columns and mRNAs in the rows. The boxes in
color indicate the log2 intensities of the mRNAs, with green indicating low expression and red indicating high expression
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regulated with fold changes over than 2, and five down-
regulated were identified in DS group versus control
group (Additional file 1: Table S1). The hierarchical clus-
ter of all covered mature miRNAs was showed in Fig. 1.
Differentially expressed mRNAs in DS group versus
control group
In order to identify potential targets of the changed miR-
NAs, the mRNA expression profile of the same hippo-
campal tissues also was investigated with Affymetrix
microarray. The results showed that 1160 mRNA were
significantly increased and 994 mRNA were significantly
decreased in DS group. And 51 up-regulated mRNA
were from chromosome 21 (Table 2). Cluster analysis of
top 40 probe sets encoding mRNAs with the highest
variation in expression across the 6 samples showed two
major clusters (Fig. 2). And cluster analysis of all the
differentially expressed mRNA was shown in Additional
file 2: Figure S1.
The GO-enrichment analysis was used to illustrate the
biological functions to the putative target mRNAs. The
target genes are predominantly involved in the biological
functions including cell cycle, meiosis, gap junction,
fructose and mannose metabolism and alanine, aspartate
and glutamate metabolism (Table 3).
Correlation between expression levels of significantly
differentially expressed miRNAs and their predicted
targets mRNAs
In order to identify target mRNAs of one or more of the
differentially expressed miRNAs that are potentially re-
lated with DS fetal neurological deficiency, we applied
two criteria, 1) the target mRNAs should be differen-
tially co-expressed together with the altered miRNAs in
DS fetal hippocampal tissues; and 2) the target mRNA
should display an inverse expression correlation with the
miRNA. Total 995 pairs of significantly altered miRNAs
and predicted target mRNAs fulfilled the criteria in DS
fetal group versus controls. Functional analysis indicated
that the gene list was significantly enriched in regulation
of transcription (Fig. 3). The proportion of significantly
altered miRNAs that involved in predicted miRNA-
target mRNAs pairs was shown in Fig. 4. The top 10
miRNA - target mRNA pairs that have the largest num-
ber of predicted results in prediction tools were listed in
Table 4. Among them, seven of the top 10 miRNA-
target mRNA pairs are related to hsa-miR-138. Cytos-
cape software suggested that hsa-miR-138 has the largest
number of mRNA neighbors. This miRNA was chosen
to validate microarray results by real time-PCR, along
with its predicted target mRNAs: MAML1, NNAT,
VEZF1, ITGB3BP, SOX11, EZH2 and CBX2. Of all
miRNA-mRNA pairs, we also selected hsa-miR-409-
5p, which played roles in cell proliferation and
apoptosis [16], along with its predicted target genes,
SMARCC1 and EFNB1, and another two miRNAs,
hsa-miR-19-3p and hsa-miR-204-5p to validate the
microarray results.
Validation of the microarray expression data by real-time
PCR
Based on the correlation analysis of miRNA and mRNA
expression, the significance levels of miRNA and mRNA
microarray data and previous literature, four miRNAs
and 15 mRNAs, including MAML1, NNAT, VEZF1,
ITGB3BP, SOX11, EZH2, EFNB1, CBX2, SMARCC1,
PCP4, C2CD2, APP, MX1, PDXK and AGPAT3 were
chosen to confirm their altered expression in DS fetal
compared to controls by real-time PCR. Consistent with
the microarray data, real-time PCR confirmed that hsa-
miR-138 and hsa-miR-409-5p were significantly increased,
hsa-miR-19-3p and hsa-miR-204-5p were decreased in DS
fetal hippocampal tissues compared with controls. Relative
expression levels of the selected miRNAs are depicted in
Fig. 5. In line with our microarray data, expression of
MAML1, NNAT,VEZF1, ITGB3BP, SOX11, EZH2, EFNB1,
CBX2, SMARCC1 was significantly decreased in DS fetal
compared to controls (Fig. 6). The expression of MX1,
APP, AGPAT3 and PDXK that located on chromosome 21
were increased in DS group vs. control group (Fig. 7),
thereby confirming results of previous studies pub-
lished elsewhere [17]. Consistent with the microarray
data, PCP4 and C2CD2, were also increased in DS
group (Fig. 7).
Table 3 15 pathways significantly influenced by differentially
expressed RNAs
KEGG pathway Genes P value
Cell cycle 428 9.4362E-09
Cell cycle - yeast 278 1.55857E-08
Gap junction 304 4.49918E-08
Oocyte meiosis 472 2.65787E-06
Progesterone-mediated oocyte maturation 346 4.63607E-05
Long-term depression 269 5.33789E-05
Prion diseases 134 0.000130518
Salivary secretion 409 0.000200115
Melanoma 249 0.000274233
Wnt signaling pathway 679 0.000387352
p53 signaling pathway 274 0.000446442
Fructose and mannose metabolism 124 0.001832756
Meiosis - yeast 259 0.002555986
Bacterial invasion of epithelial cells 440 0.002752716
Alanine, aspartate and glutamate metabolism 101 0.002969861
Genes number of genes involved in the KEGG pathway
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EZH2 is a direct target of hsa-miR-138
EZH2 had a pupative hsa-miR-138 binding site with its
3′UTR. To test whether EZH2 was a direct target of
hsa-miR-138, a construct of 3′UTR of EZH2 fused
downstream of the firefly luciferase gene was generated.
pMIR-REPORT-EZH2 3′ UTR was transfected with hsa-
miR-138 mimics or none-target control together into
HEK293T cells. The results showed that hsa-miR-138
overexpression reduced the EZH2 3′UTR luciferase
reporter activity compared to none-target control
transfected group (Fig. 8a). In addition, real-time PCR
analysis showed that hsa-miR-138 overexpression sig-
nificantly decreased EZH2 mRNA level in HEK293T
cells (Fig. 8b). These results indicated that EZH2 was a
direct target of hsa-miR-138 in HEK293T cells.
Discussion
Down syndrome is one of the most common chromo-
somal abnormalities among live born infants. The major
neurological deficits that afflict DS individuals are intel-
lectual disability and the early onset of Alzheimer’s
disease [4]. Numerous abnormalities in the DS nervous
system have been reported. In nervous system, the onset
of Alzheimer’s disease has been intensively studied, while
the mechanisms of intellectual disability in DS patients
have not been well elucidated. The goal of our study
was to establish a comprehensive picture of miRNA-
mRNA network that could cause neurological defi-
ciency especially intellectual disability in fetal Down
syndrome. To our best knowledge, this study is the
first whole-genome miRNA and mRNA expression
microarray profiling in hippocampal tissues of human
fetal Down syndrome, will therefore provide a clue to
study the mechanisms of neurological deficiency oc-
curred in DS patients.
MicroRNAs are known to regulate the expression of
genes post-transcriptionally. They are involved in a wide
range of biological processes, such as proliferation,
apoptosis, tumor development, stress response etc. In
our study, the differentially expressed miRNAs in hippo-
campus of DS fetal suggested an association with DS
neurological problems. Based on the amplified
Fig. 3 Enrichment of biological processes in term of Gene Ontology categories with predicted miRNA-mRNA pairs. A number of biological
processes were enrichment with predicted miRNA-mRNA pairs. The number of genes in each GO category is indicated within the plot
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developmental instability hypothesis [18] of DS that a
number of trisomic genes result in a genetic imbalance,
we assumed that these differentially expressed miRNAs
participated in the complicated genetic imbalance in DS
patients. Correlation analysis between miRNA and the
predicted target mRNA expression levels showed that
hsa-miR-138 were involved most frequently in signifi-
cantly inversely correlated miRNA-target mRNA
pairs. The hsa-miR-138 has been previously demon-
strated to have essential roles in tumor suppression.
It was down-regulated in various cancers [19, 20]. In
this research, we found that hsa-miR-138 is up-
regulated in hippocampus from DS fetal. The func-
tion of hsa-miR-138 in cell proliferation and cell
apoptosis may affect the normal development of
hippocampus. In our study, the expression of hsa-
miR-155 and let-7c that from chromosome 21 also
were increased in DS group. But there was no
significant difference between two groups, which is
probably due to the small sample size and sample
variability.
The EZH2 protein is the catalytic core protein in the
Polycomb group (PcG) repressive complex 2 (PRC2),
which are involved in epigenetic regulation of gene ex-
pression. EZH2 plays important roles in the progress of
cell fate decision, cell cycle regulation, senescence, cell
differentiation and cancer. EZH2, has highly conserved
putative hsa-miR-138 binding site within its 3′UTR, has
been proved as one of directly targets of hsa-miR-138
[21]. The functional role of EZH2 has already been stud-
ied extensively. In animal model, it was shown that
EZH2, which formed a PcG complex with EED (embry-
onic ectoderm development), could induce an ectopic
neural axis in neural induction [22]. The mutation of
EZH2 were related to primary central nervous system
lymphoma [23]. Moreover, muted EZH2 led to Weaver
Syndrome that had intellectual disability as one of its
common features [24]. In this research, EZH2 is down-
regulated in hippocampal tissues in DS versus control
samples, which implied that EZH2 also play roles in
neurological deficiency of DS especially in intellectual
disability.
Amyloid beta/A4 precursor protein (APP) has been
shown essential roles in Alzheimer’s disease (AD)
[25, 26] and in autism [27]. In this research, APP
was up-regulated that implied its potential role in
Down Syndrome.
Fig. 4 The proportion of miRNAs that involved in predicted miRNA-mRNA pairs. The number of predicted miRNA-mRNA pairs of each miRNA
was indicated within the plot. Hsa-miR-138 had the maximum predicted target mRNAs among all the pairs
Table 4 Top 10 most significantly correlated miRNA-mRNA pairs
MiRNAs Predicated target Correlation P. value SUM
hsa-miR-138 EZH2 −1 0.002777778 9
hsa-miR-138 DVL2 −1 0.002777778 7
hsa-miR-485-3p TRIM24 −1 0.002777778 7
hsa-miR-138 ARRDC3 −1 0.002777778 7
hsa-miR-138 DVL2 −1 0.002777778 7
hsa-miR-138 NNAT −1 0.002777778 7
hsa-miR-138 VEZF1 −1 0.002777778 7
hsa-miR-770-5p BTG1 −1 0.002777778 7
hsa-miR-138 NNAT −1 0.002777778 7
hsa-miR-770-5p BTG1 −1 0.002777778 7
SUM The total of predicated miRNA-mRNA pairs in ten different
prediction tools
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Fig. 5 miRNA expression level was examined by real-time PCR. The expression of hsa-miR-138 (a), hsa-miR-409 (b), hsa-miR-19 (c) and hsa-miR-204
(d) were tested in fetal hippocampus tissues of DS and control group. The expression of hsa-miR-138 and hsa-miR-409 were obviously increased in
DS group compared to control group. The expression of hsa-miR-19 and hsa-miR-204 were reduced in DS group compared to control
group. The expression of hsa-miR-138, hsa-miR-409 and hsa-miR-19 showed significant difference between two groups. The miRNAs
expression was normalized to U6 expression. The asterisks indicate the statistically significant difference
Fig. 6 The predicted targets of hsa-miR-138 and hsa-miR-409 were reduced examined by real-time PCR. The selected mRNA level was tested in
fetal hippocampus tissues of DS and control group. All the selected mRNA was reduced in DS group compared to control group. The mRNAs
expression was normalized to GAPDH. The expression of EZH2, NNAT, SMARCC1, MAML1 and SOX11 showed significant difference between two
groups. The asterisks indicate the statistically significant difference
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In this research, we focused on the miRNA and its
predicted mRNA in hippocampus of DS. There are some
limitations to our study. Firstly, we used a relatively
small sample size. Microarray analysis was performed
using the RNA extracted from three samples in each
group, and the validation experiments were performed
using four samples in DS group and three samples in
control group. However, significant differences could be
identified in gene expression. Secondly, correlation
analysis suggested a highly significant negative correl-
ation between expression levels of hsa-miR-138 and
its potential target mRNAs of interest. We need to
further determine whether these mRNAs are targeted
by endogenous miRNAs in hippocampus. Neverthe-
less, our data provide a clue regarding hsa-miR-138
and its targets EZH2 are associated with neurological
Fig. 7 mRNA expression level was examined by real-time PCR. The selected mRNA located on chromosome 21, including MX1, APP, AGPAT3 and
PDXK, were increased in DS group compared to control group. The mRNAs expression was normalized to GAPDH. PCP4 and C2CD2 were
also increased in DS group. The expression of MX1, APP, PDXK, PCP4 and C2CD2 showed significant difference between two groups. The
asterisks indicate the statistically significant difference
Fig. 8 Hsa-miR-138 downregulated EZH2 by interacting with its 3′UTR. a The pMIR-REPORT-EZH2 3′ UTR was cotransfected into HEK293T
cells with hsa-miR-138 mimics or none-target control. b the expression of EZH2 mRNA was tested by real-time PCR. GAPDH was served as
an internal control
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deficiency in DS. Further analysis of our microarray
data will help us to understand the mechanism of
neurological deficiency in DS patients.
Conclusion
This research represents an integrated analysis of
miRNA and mRNA expression in hippocampus of DS
fetal. We identified a number of differentially expressed
miRNA and its predicted mRNA, including hsa-miR-138
and its target EZH2. It is presumed that hsa-miR-138
and EZH2 could be involved in neurological deficiency
of DS patients. It will help better understand intellectual
disability development in DS. While the mechanisms as
to how hsa-miR-138 targets EZH to play roles in DS
needs to be further studied.
Additional files
Additional file 1: Table S1. List of differentially expressed miRNA in DS
group versus control group by microarray assay. Red indicates increased
expression of miRNA and green indicates decreased expression of miRNA
in DS group versus control group. (XLSX 102 kb)
Additional file 2: Figure S1. Heatmap of mRNA expression in fetal
hippocampus of DS fetal cohorts and control cohorts. Hierarchical
clustering of all samples based on the log2 expression values of all
differentially expressed mRNAs. Samples are shown in the columns
and mRNAs in the rows. The boxes in color indicate the log2 intensities
of the mRNAs, with green indicating low expression and red indicating
high expression. (JPG 455 kb)
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